YUFLYMA® (adalimumab-aaty) is a high-concentration (100mg/mL) and citrate-free formulation of Humira® (adalimumab) biosimilar, that is now interchangeable [1] Interchangeable designation of YUFLYMA® is supported by positive data from the Phase III interchangeability study in patients with...
Read More Details
Finally We wish PressBee provided you with enough information of ( U.S. FDA grants interchangeable designation to YUFLYMA® (adalimumab-aaty), Celltrion's biosimilar to Humira® (adalimumab) )
Also on site :
- Deaths reported during protests in Kenya (VIDEO)
- Man accused of pointing gun at troopers during I-90 standoff set to be arraigned
- Amazon Is Selling 'Very Pretty' $40 Vera Bradley Wristlets for Just $11, and Shoppers Say They’re the 'Perfect Size'